Clinical Trial

The Effect of Gender-affirmative Measures on Breast Perception in Trans Men

Study acronym: TRANSBREAST
Recruiting
View on ClinicalTrials.gov →
Summary
Breast dysphoria in transmasculine or genderdiverse individuals is a distinct psychological burden associated with depression, anxiety and suicidality. The aim is to systematically investigate the effect of GAHT (gender-affirming hormone therapy) and mastectomy on this form of dysphoria. The primary objective of this study is to analyse and investigate the psychological and physical effects of breast development on trans men or genderdiverse individuals. A secondary objective is to determine the extent to which the stress affects the well-being of trans men depending on the coping strategies used (binding vs. taping).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-25.
Status change: Not Yet Recruiting → Recruiting 2026-03-04
Trial Details
NCT Number NCT07252687
Lead Sponsor Medical University Innsbruck
Conditions Transgender, Gender Dysphoria in Adolescents and Adults
Enrollment 100 participants
Start Date 2025-11-30
Primary Completion 2030-11 (estimated)
Study Completion 2030-11 (estimated)
Updated on ClinicalTrials.gov 2026-03-06